anjali grover, md

Clinical CorrelationsClinical Correlations The NYU Internal Medicine Blog The NYU Internal Medicine Blog

A Daily Dose of MedicineA Daily Dose of Medicine

http://clinicalcorrelations.org

Medical Grand RoundsMedical Grand RoundsClinical VignetteClinical Vignette

December 17December 17thth, 2008, 2008

Anjali Grover, M.D.Anjali Grover, M.D.

Chief ComplaintChief Complaint

A 45 year old Hispanic male presents with A 45 year old Hispanic male presents with chest pain for 45 minutes.chest pain for 45 minutes.

History of Present IllnessHistory of Present Illness

• The patient was well until the evening of The patient was well until the evening of admission when he had the sudden onset admission when he had the sudden onset of non-radiating, sub-sternal chest of non-radiating, sub-sternal chest pressure while walking. pressure while walking.

• The chest pain was associated with mild The chest pain was associated with mild shortness of breath, light-headedness, shortness of breath, light-headedness, palpitations, diaphoresis and nausea palpitations, diaphoresis and nausea without vomiting. without vomiting.

Additional HistoryAdditional History

Past Medical History: Past Medical History: – HyperlipidemiaHyperlipidemia– DepressionDepressionPast Surgical History:Past Surgical History: none noneSocial history:Social history:

– Current smoker with a 25 pack year historyCurrent smoker with a 25 pack year history– Denies ethanol or illicit drug useDenies ethanol or illicit drug useFamily History:Family History:

– Mother died of a myocardial infarction at age 76Mother died of a myocardial infarction at age 76Allergies: Allergies:

– No known drug allergiesNo known drug allergiesMedications:Medications:

-- Simvastatin 40 mg daily-- Simvastatin 40 mg daily-- Aspirin 81 mg daily-- Aspirin 81 mg daily-- Fluoxetine 20 mg daily-- Fluoxetine 20 mg daily

Physical ExamPhysical ExamGeneral:General: In mild distress, appeared his stated age.In mild distress, appeared his stated age.

T:97.1T:97.1ooF BP:159/82 HR:84 RR:16 F BP:159/82 HR:84 RR:16 OO2:97%RA:97%RA

The remainder of the physical exam was normalThe remainder of the physical exam was normal

LaboratoryLaboratory

Basic Metabolic Panel normalBasic Metabolic Panel normalComplete Blood Count normalComplete Blood Count normalHepatic Function Panel normalHepatic Function Panel normal

Time 0 hours Time 8 hours

Troponin 0.09 (normal <0.07) 0.01

ImagingImagingECG: ECG: Sinus rhythm with rate of 63, 2 mm ST elevation Sinus rhythm with rate of 63, 2 mm ST elevation in V2, 1 mm up-slanting ST depression in II, III, aVf.in V2, 1 mm up-slanting ST depression in II, III, aVf.

Chest X-RayChest X-Ray: : No evidence of pulmonary congestion, No evidence of pulmonary congestion, infiltrate or effusions.infiltrate or effusions.

Working DiagnosesWorking Diagnoses

Acute Coronary Syndome: ST Elevation Acute Coronary Syndome: ST Elevation Myocardial Infarction (STEMI)Myocardial Infarction (STEMI)

Brugada SyndromeBrugada Syndrome

Hospital CourseHospital CourseEmergency Room course: Emergency Room course:

– Treated with: Treated with: Aspirin 325mgAspirin 325mg

Clopidogrel 300mgClopidogrel 300mg

Lopressor 5 mg IVP x 3Lopressor 5 mg IVP x 3

Morphine 4mg IVPMorphine 4mg IVP

Sub-lingual Nitroglycerine 0.4mg x 3Sub-lingual Nitroglycerine 0.4mg x 3

Heparin drip Heparin drip

Lipitor 80 mgLipitor 80 mg

The patient remained hemodynamically The patient remained hemodynamically stable, EKG changes were stable and stable, EKG changes were stable and his chest pain resolved. his chest pain resolved.

Hospital CourseHospital CourseHospital Day #1: Cardiac Catheterization revealed clean coronary

arteries Transthoracic Echocardiogram showed no

abnormalities

Hospital Day #2: Procainamide challenge performed to evaluate for

possible manifestations of Brugada Syndrome on EKG.

With procainamide, the patient’s 2mm “saddle-back” ST segment elevation in V2 converted to a “coved” ST segment elevation pattern.

These findings represented a positive procainamide challenge.

Hospital CourseHospital CourseHospital Day #3:Hospital Day #3: Electrophysiology Study performed for further risk stratification Electrophysiology Study performed for further risk stratification

revealed no inducible ventricular arrhythmias. revealed no inducible ventricular arrhythmias.

ICD placement was recommended to the patient, but he ICD placement was recommended to the patient, but he refused.refused.

He was discharged on Aspirin and Zocor.He was discharged on Aspirin and Zocor.

6 months later on follow-up in Cardiology Clinic, the 6 months later on follow-up in Cardiology Clinic, the patient agreed to ICD placement. It was placed shortly patient agreed to ICD placement. It was placed shortly thereafter.thereafter.

Final DiagnosisFinal Diagnosis

Type 2 Brugada SyndromeType 2 Brugada Syndrome